Selective and sequential transarterial chemoembolization: Survival in patients with hepatocellular carcinoma

European Journal of Radiology

Volumn 81, Issue 9, 2012, Pages 2290-2297

  Antoch, Gerald ^a   Roelle, Grit ^a   Ladd, Susanne C ^a   Kuehl, Hilmar ^a   Heusner, Till A ^a   Sotiropoulos, Georgios C ^a   Hilgard, Philip ^a   Forsting, Michael ^a   Verhagen, Ruediger ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Chemoembolization; Embolization; HCC; Hepatocellular carcinoma; TACE

Indexed keywords

IODINATED POPPYSEED OIL;

ACUTE ABDOMEN; ADULT; AGED; ARTERY BLOOD FLOW; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CATHETERIZATION; CHEMOEMBOLIZATION; FEMALE; HEPATIC ARTERY; HISTOPATHOLOGY; HUMAN; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FUNCTION; LIVER RUPTURE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PLEURA EFFUSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SCORING SYSTEM; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; ETHIODIZED OIL; FEMALE; GERMANY; HEMOSTATICS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; PREVALENCE; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84864676591     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2011.09.010     Document Type: Article

References (24)

1. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
2. J. Bruix, M. Sala, and J.M. Llovet Chemoembolization for hepatocellular carcinoma Gastroenterology 127 2004 S179 S188
3. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442
4. C. Camma, F. Schepis, A. Orlando, M. Albanese, L. Shahied, and F. Trevisani Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 2002 47 54
5. J.M. Llovet, M.I. Real, X. Montana, R. Planas, S. Coll, and J. Aponte Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
6. C.M. Lo, H. Ngan, W.K. Tso, C.L. Liu, C.M. Lam, and R.T. Poon Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171
7. G. Pelletier, M. Ducreux, F. Gay, M. Luboinski, H. Hagege, and T. Dao Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC J Hepatol 29 1998 129 134
8. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire N Engl J Med 332 1995 1256 1261
9. G. Pelletier, A. Roche, O. Ink, M.L. Anciaux, S. Derhy, and P. Rougier A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma J Hepatol 11 1990 181 184
10. L. Marelli, R. Stigliano, C. Triantos, M. Senzolo, E. Cholongitas, and N. Davies Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 2007 6 25
11. V.P. Chuang, and S. Wallace Chemoembolization: transcatheter management of neoplasms JAMA 245 1981 1151 1152
12. J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, and A.K. Burroughs Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
13. D.B. Brown, J.E. Gould, D.A. Gervais, S.N. Goldberg, R. Murthy, and S.F. Millward Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria J Vasc Interv Radiol 18 2007 1469 1478
14. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, and R. Williams Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
15. C. Child, and J. Turcotte Surgery and portal hypertension 1964 Saunders
16. K. Okuda, T. Ohtsuki, H. Obata, M. Tomimatsu, N. Okazaki, and H. Hasegawa Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 1985 918 928
17. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators Hepatology 31 2000 840 845
18. J.M. Llovet, C. Bru, and J. Bruix Prognosis of hepatocellular carcinoma: the BCLC-staging classification Semin Liver Dis 19 1999 329 338
19. C.J. Leoni, J.E. Potter, M.P. Rosen, D.P. Brophy, and E.V. Lang Classifying complications of interventional procedures: a survey of practicing radiologists J Vasc Interv Radiol 12 2001 55 59
20. S. Kawai, J. Okamura, M. Ogawa, Y. Ohashi, M. Tani, and J. Inoue Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma - a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan Cancer Chemother Pharmacol 31 Suppl. 1992 S1 S6
21. N. Matsuo, H. Uchida, H. Sakaguchi, K. Nishimine, Y. Nishimura, and S. Hirohashi Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings Semin Oncol 24 1997 S6-61-S6-70
22. O. Ernst, G. Sergent, D. Mizrahi, O. Delemazure, J.C. Paris, and C. L'Hermine Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response AJR Am J Roentgenol 172 1999 59 64
23. O. Matsui, M. Kadoya, J. Yoshikawa, T. Gabata, T. Takashima, and H. Demachi Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate Cancer Chemother Pharmacol 33 Suppl. 1994 S84 S88
24. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, J. Raoul, and S. Zeuzem Sorafenib improves survival in advanced hepatocellular carcinoma (HCC): results of a Phase III randiomized placebo-controlled trial (SHARP trial) J Clin Oncol 25 2007 18S